What does AbbVie do?

AbbVie Inc. researches and develops pharmaceutical products. The Company produces pharmaceutical drugs for specialty therapeutic areas such as immunology, chronic kidney disease, hepatitis C, women's health, oncology, and neuroscience. AbbVie also offers treatments for diseases including multiple sclerosis, parkinson's, and alzheimer's disease.

Is AbbVie (abbv) a good stock to buy?

AbbVie (ABBV) closed at $165.99 in the latest trading session, marking a +0.36% move from the prior day. The Icelandic biotech company has a deal to expand the reach of its Humira biosimilar in Eastern Europe. A couple of potential stocks that you can confidently hold forever are AbbVie (NYSE: ABBV) and Coca-Cola (NYSE: KO).

Does AbbVie (abbv) dip more than broader markets?

AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know. AbbVie (ABBV) closed the most recent trading day at $66.70, moving -1.36% from the previous trading session.

Is AbbVie a tax inversion?

On 25 June 2019, AbbVie announced it would acquire Irish-based Allergan plc for about $63 billion; however the transaction would not be structured as a tax inversion, and that post the transaction, AbbVie would remain legally domiciled in the U.S. for tax purposes.